4.2 Article

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations

Tjalf Ziemssen et al.

Summary: This study suggests that serum concentrations of neurofilament light chain (sNfL) may serve as a marker of brain injury in Wilson's disease and complement the clinical and neuroimaging disease severity scales.

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease - the neuroradiological correlations

Barbara Redzia-Ogrodnik et al.

Summary: Wilson's disease is a genetic disorder characterized by copper accumulation and associated clinical symptoms in various organs. A study analyzed the relationship between MRI brain pathology and disease severity in Wilson's disease patients. The findings suggest that brain MRI changes may be present even in patients without neurological symptoms, and a semiquantitative MRI scale appears to be a useful tool for assessing brain injury severity in these patients.

NEUROLOGICAL SCIENCES (2022)

Article Genetics & Heredity

Clinical and Genetic Analysis in Neurological Wilson's Disease Patients With Neurological Worsening Following Chelator Therapy

Haiman Hou et al.

Summary: This study aimed to explore the genetic effect on neurological worsening in neurological WD patients following chelator therapy. The results showed that younger age of onset, presence of dystonia, and genotype with severe mutations were associated with an increased risk of neurological deterioration.

FRONTIERS IN GENETICS (2022)

Article Clinical Neurology

Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease

Samuel Shribman et al.

Summary: Neurofilament light (NfL) concentrations were higher in neurological presentations of Wilson's disease, making it a potential biomarker for guiding chelation therapy and clinical trials.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients

Rebecca De Lorenzo et al.

Summary: The study investigated the clinical prognostic value of markers of neural tissue damage in predicting survival or transfer to ICU in patients infected with COVID-19. Results showed that certain markers were significantly increased in patients with fatal outcomes or needing ICU transfer, with total tau levels accurately predicting mortality. Blood neural markers may offer additional prognostic value for predicting COVID-19 outcomes.

JOURNAL OF NEUROLOGY (2021)

Review Oncology

Wilson disease-treatment perspectives

Tomasz Litwin et al.

ANNALS OF TRANSLATIONAL MEDICINE (2019)

Review Clinical Neurology

Neurofilaments as biomarkers in neurological disorders

Michael Khalil et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Medicine, General & Internal

Wilson disease

Anna Czlonkowska et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Article Clinical Neurology

Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis

Giulio Disanto et al.

ANNALS OF NEUROLOGY (2017)

Article Clinical Neurology

Early neurological worsening in patients with Wilson's disease

Tomasz Litwin et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Wilson’s disease

JOURNAL OF HEPATOLOGY (2015)

Article Endocrinology & Metabolism

Clinical considerations for an effective medical therapy in Wilson's disease

Karl Heinz Weiss et al.

HUMAN DISORDERS OF COPPER METABOLISM II (2014)

Editorial Material Gastroenterology & Hepatology

Long-term Outcome for Wilson Disease: 85% Good

Michael L. Schilsky

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Long-term Outcomes of Patients With Wilson Disease in a Large Austrian Cohort

Sandra Beinhardt et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Clinical Neurology

Worsening of Wilson Disease following Penicillamine Therapy

Jayantee Kalita et al.

EUROPEAN NEUROLOGY (2014)

Article Gastroenterology & Hepatology

Long term results of liver transplantation for Wilson's disease: Experience in France

Olivier Guillaud et al.

JOURNAL OF HEPATOLOGY (2014)

Article Biochemical Research Methods

pROC: an open-source package for R and S plus to analyze and compare ROC curves

Xavier Robin et al.

BMC BIOINFORMATICS (2011)

Article Gastroenterology & Hepatology

Zinc Monotherapy Is Not as Effective as Chelating Agents in Treatment of Wilson Disease

Karl Heinz Weiss et al.

GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders

V Medici et al.

LIVER TRANSPLANTATION (2005)

Article Medicine, General & Internal

Prognostic factors in patients presenting with severe neurological forms of Wilson's disease

LK Prashanth et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)

Article Clinical Neurology

Wilson's disease - cause of mortality in 164 patients during 1992-2003 observation period

A Czlonkowska et al.

JOURNAL OF NEUROLOGY (2005)

Article Gastroenterology & Hepatology

Diagnosis and phenotypic classification of Wilson disease

P Ferenci et al.

LIVER INTERNATIONAL (2003)